Avoidable Mortality Case Note Review Trial
NCT01998191 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2022-05-05
Summary
TITLE A randomized controlled trial to assess the best method for evaluating avoidable mortality in hospitals using medical record review.
DESIGN Randomised controlled trial This trial will be conducted in concordance with the CONSORT guidelines for randomised controlled trials.
AIMS Compare explicit versus implicit case review methods for detecting avoidable mortality in patients who have died in hospital Assess the accuracy and efficiency of physicians versus nurses in detecting avoidable mortality in patients who have died in hospital
OUTCOME MEASURES Rate of adverse event detection between explicit and implicit review methods Type of adverse event detection between explicit and implicit review methods
Kappa score of agreement for inter-rater reliability for the above outcomes:
* Between individual reviewers within using the same review method
* Between different reviewer types.
PARTICIPANTS Physician reviewers and nurses No patient participation. Case records of patients who had inpatient hospital mortality will be reviewed.
ELIGIBILITY Over 18, Able to consent, English Language Speaking, Able to participate in case note review training, appropriate level of clinical experience.
DURATION 2 years with extension if required and reviewed.
Conditions
- In Hospital Mortality
Interventions
- OTHER
-
Explicit case note review checklist (nurse)
A checklist to be used to screen notes for features of avoidable death used by nurses. to be compared with 'Implicit Case note review (physician)' 'Implicit Case note review (MDT)' 'Implicit Case note review (nurse)' and the other two intervention arms.
- OTHER
-
Explicit case note review checklist (physician)
A checklist to be used to screen notes for features of avoidable death, used by a nurse. to be compared with 'Implicit Case note review (physician)' 'Implicit Case note review (MDT)' 'Implicit Case note review (nurse)' and the other two intervention arms.
- OTHER
-
Explicit case note review checklist (MDT)
A checklist to be used to screen notes for features of avoidable death used by a nurse and an expert physician. to be compared with 'Implicit Case note review (physician)' 'Implicit Case note review (MDT)' 'Implicit Case note review (nurse)' and the other two intervention arms.
Sponsors & Collaborators
-
Imperial College London
lead OTHER
Principal Investigators
-
Ara Darzi · Imperial College London
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-02-28
- Primary Completion
- 2023-01-31
- Completion
- 2023-01-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Study of MHE in Patients With Liver Diseases
NCT04058327 ·Status: COMPLETED
-
Recall of a Cohort of Subjects in the Mediterranean Area. Monitoring of Liver Diseases (NUTRIHEP 3).
NCT06931925 ·Status: NOT_YET_RECRUITING
-
Effect of Tolvaptan on Cognitive Function in Cirrhosis
NCT01556646 ·Status: COMPLETED ·Phase: PHASE3
-
Complex Exploratory Study of Alcohol-Associated Hepatitis
NCT06358196 ·Status: NOT_YET_RECRUITING
-
Nurse Assisted Post-discharge Intervention in Decompensated Cirrhosis
NCT04158986 ·Status: COMPLETED ·Phase: NA
-
Effect of Re-education on Rebleeding Rate After Endoscopic Treatment in Liver Cirrhosis
NCT05302661 ·Status: UNKNOWN ·Phase: NA
-
To Evaluate the Safety and Efficacy of Preemptive Administration of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema
NCT04991259 ·Status: UNKNOWN ·Phase: NA
-
Prothrombin Time Predicts Steroid Response in Severe Alcoholic Hepatitis.
NCT05883891 ·Status: COMPLETED
-
RCA for CRRT in Liver Failure and High Risk Bleeding Patients
NCT03791190 ·Status: UNKNOWN ·Phase: NA
-
Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation
NCT02084160 ·Status: COMPLETED
-
Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites
NCT02173288 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Heparin Like Effect in Acute Variceal Bleeding
NCT04111120 ·Status: UNKNOWN
-
Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy
NCT01559519 ·Status: COMPLETED ·Phase: PHASE4
-
Short Term Outcomes in Hospitalized Patients With Liver Cirrhosis
NCT05848414 ·Status: COMPLETED
-
Risk Factors and Outcomes of Acute Venous Thromboembolism in Cirrhotic
NCT03580577 ·Status: UNKNOWN
-
MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis
NCT03438916 ·Status: COMPLETED
-
Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis
NCT02526303 ·Status: WITHDRAWN ·Phase: NA
-
Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival
NCT06431919 ·Status: RECRUITING ·Phase: NA
-
RCT to Determine the Efficacy of Combining Hemospray With Medical Treatment in Acute Variceal Bleeding
NCT03061604 ·Status: COMPLETED ·Phase: NA
-
TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
NCT02485184 ·Status: UNKNOWN ·Phase: NA
-
cACLD in Patients With Alcohol Use Disorder in the Hospital Detoxification Unit
NCT06838468 ·Status: ENROLLING_BY_INVITATION
-
To Study the Hemodynamic Response of Early Addition of Carvedilol to Terlipressin in Acute Variceal Bleed in Child's B and C Cirrhosis
NCT05699824 ·Status: UNKNOWN ·Phase: NA
-
Tolvaptan for Ascites in Cirrhotic Patients
NCT01292304 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests
NCT07087041 ·Status: NOT_YET_RECRUITING
-
Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis
NCT00886925 ·Status: COMPLETED ·Phase: PHASE4